Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Indometacin
The Boots Company Plc
M01AB01
Indometacin
50mg
Oral capsule
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 10010100
296x210 Leaflet Reel Fed Bi Fold Profile (BST) Dimensions: Component: Date Sent: Technologist: TECHNICALLY APPROVED Pharmacode: JDE No.: Indometacin Hard Capsules 25, 50mg x 28’s (UK) 296x210 (Reel Fed) 50967738 Leaflet for Blisters 4453 T. Hull 01/05/19 * Please note that ONLY Artwork Studio is permitted to make changes to the above artwork. No changes are permitted by any 3rd party other than added notes and mark ups for required changes. approved for print/date PROOF ROUND UK-Eire-Artwork-Support@accord-healthcare.com Technical Approval NON PRINTING COLOURS COLOURS DATE SENT: DATE RECEIVED: Item number: ORIGINATOR: ORIGINATION DATE: REVISION DATE: REVISED BY: DIMENSIONS: MIN BODY TEXT SIZE: SUPPLIER: 1. 2. 3. 4. 5. 6. 1. 2. 3. FMD info NA (not a carton) No Yes Details INDOMETACINE 25MG & 50MG 28 TABS PIL - UK Black Profile BBBA4736 RH 09-05-19 11-11-19 RH 296x210 10pt Accord Barnstaple NA NA 05 Version 2 01.11.2017 page 4 page 1 50967738 BBBA4736 page 4 page 1 INDOMETACIN 25MG AND 50MG CAPSULES READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1 WHAT INDOMETACIN CAPSULES ARE AND WHAT THEY ARE USED FOR 2 WHAT YOU NEED TO KNOW BEFORE YOU TAKE INDOMETACIN CAPSULES 3 HOW TO TAKE INDOMETACIN CAPSULES 4 POSSIBLE SIDE EFFECTS 5 HOW TO STORE INDOMETACIN CAPSULES 6 CONTENTS OF THE PACK AND OTHER INFORMATION 1 WHAT INDOMETACIN CAPSULES ARE AND WHAT THEY ARE USED FOR Indometacin capsules belong to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). These medicines ar Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Indometacin 50mg Capsules and Inflamid 50mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 50 mg indometacin For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Indometacin capsules are size 1 hard gelatin capsules 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Indometacin has non-steroidal analgesic and anti-inflammatory properties. Indometacin is indicated for the treatment of: o active stages of rheumatoid arthritis o ankylosing spondylitis o osteoarthritis o acute musculoskeletal disorders o acute gout o lumbago o degenerative joint disease of the hip o inflammation, pain, and oedema following orthopaedic procedures o pain and associated symptoms of primary dysmenorrhoea Since Indometacin is not a simple analgesic, its use should be limited to the above conditions. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY The dose should be carefully adjusted to suit the needs of the individual patient, starting with a low dose._ _ Indometacin should be taken with food, milk or immediately after meals, or with an antacid to lessen gastric disturbances. In chronic conditions start the therapy with a low dose, increasing as required. USE IN ADULTS Recommended oral dosage range is 50-200mg daily._ _ _ACUTE RHEUMATOID ARTHRITIS:_ Initially 25mg two or three times a day. _CHRONIC RHEUMATIC DISORDERS:_ 25mg two or three times daily. (If response is inadequate, gradually increase by 25mg, adequate response is usually achieved with not more than 150mg daily, rarely more than 200mg daily). _SUDDEN FLARE UP OF CHRONIC CONDITION:_ Increase if necessary, by 25mg daily until a satisfactory response is obtained, or a dosage of 150-200mg daily is reached. (If this causes any adverse effects, it should be reduced to a tolerable level for two or three days, then carefully increased, as tolerated). _ACUTE MUSCULOSKELETAL DISORDERS:_ Initially 50mg two or three times daily, according to severity for 10- 14 days. Normally 150mg da Read the complete document